Active wound care market seen rising to $2.37B by 2030

The active wound care market is projected to grow from $1.6 billion in 2025 to $1.74 billion in 2026, then reach $2.37 billion by 2030, according to The Business Research Company. The report points to rising diabetes, chronic wound cases and broader adoption of advanced therapies as key drivers, with North America holding the largest regional share in 2025.

Why it matters: - The active wound care market is expanding as chronic wounds, diabetic ulcers and infection risks increase worldwide. - Faster healing, better infection control and more home-based wound management can reduce complications and improve patient outcomes. - The market’s growth signals sustained demand for advanced dressings, growth factors and skin substitutes.

What happened: - The Business Research Company released a competitive landscape analysis of the active wound care market. - The market is forecast to grow from $1.6 billion in 2025 to $1.74 billion in 2026, reflecting 8.4% growth. - The market is projected to reach $2.37 billion by 2030 at an 8.1% compound annual growth rate. - North America held the largest market share in 2025.

The details: - Active wound care focuses on removing dead or damaged tissue to support healing. - Products in the category include films, foams and hydrogels that act as barriers to infection. - Core goals include debriding unhealthy tissue, managing infection and pain, and encouraging new tissue growth. - Historical growth has been supported by limited access to advanced wound care, rising chronic wound cases, more wound care procedures in hospitals and clinics, greater awareness of diabetic foot ulcers and continued use of conventional dressings. - Future growth is expected to come from bioengineered skin substitutes, more use of growth factors, expansion of home care wound management, higher funding for chronic wound research and smart wound monitoring technologies. - Key trends include broader use of advanced wound dressings, more tissue regeneration growth factors, more treatment for chronic and acute wounds, preference for biomaterials and skin substitutes, and stronger focus on infection control and pain relief. - The report covers Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa, along with North America. - North America’s lead is tied to advanced healthcare infrastructure, wide adoption of innovative wound care technologies and high awareness of chronic wound management.

Between the lines: - Diabetes remains a major demand driver because elevated blood glucose can lead to sores, ulcers and serious infections. - The International Diabetes Federation reported in April 2025 that 589 million adults ages 20 to 79 were living with diabetes worldwide, equal to 11.1% of that age group. - The International Diabetes Federation projects the global diabetic population will rise to 853 million, or 13%, by 2050. - About 252 million adults with diabetes remain undiagnosed, which suggests more untreated wound complications may emerge. - The report’s emphasis on biomaterials, skin substitutes and smart monitoring points to a market moving toward more technology-driven care. - The new 2026 report package adds market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel forecasting dashboards, market hotspots infographics, and updated graphics and tables.

What's next: - The market is expected to keep growing through 2030 as treatment technologies improve and chronic wound cases rise. - Wider use of smart wound monitoring and home care management could expand the market beyond traditional hospital settings. - Continued research funding may accelerate adoption of newer products and therapies. - Download a free sample of the active wound care market report - View the full active wound care market report

The bottom line: - The active wound care market is on a steady growth path, with diabetes, chronic wounds and advanced treatment adoption driving demand worldwide.